clinical trial safety
Keros Therapeutics Halts Higher Dose Arms in PAH Trial Due to Pericardial Effusion Concerns
Keros Therapeutics, TROPOS trial, pulmonary arterial hypertension (PAH), cibotercept (KER-012), pericardial effusion, clinical trial safety